![SI040210: Drotaverine-d10.HCl label-new 2-{2-[2-(Prop-2-ynyloxy)ethoxy]ethoxy}ethyl β-D-lactopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/SI040210.svg?v=1699651271)
Pay in 4 interest-free payments of $143.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
2-{2-[2-(Prop-2-ynyloxy)ethoxy]ethoxy}ethyl β-D-lactopyranoside
Abnormal Akt signaling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells
1-Dimethylethyl)-N-[6-(2-hydroxyethoxy-d4)-5-(2-methoxyphenoxy)[2
47 / / Dihydroartemisinin-12-α-O-β-D-Glucuronide / Dihydroartemisinin Glucuronide
2-Thioethyl α-L-rhamnopyranoside
SI040210: Drotaverine-d10.HCl label-new 2-{2-[2-(Prop-2-ynyloxy)ethoxy]ethoxy}ethyl β-D-lactopyranosideC24H21D10NO4. HCl 444. 03 Antispasmodic Drotaverine d10. HCl Drotaverin d10
US$ 79.00
US$ 1125.00
US$ 600.00
US$ 137.50
US$ 600.00
US$ 99.00
US$ 155.00
US$ 149.00
US$ 109.00
US$ 99.00
US$ 95.00
US$ 425.00
